BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2020 3:33:10 AM | Browse: 656 | Download: 925
 |
Received |
|
2019-12-27 13:55 |
|
Peer-Review Started |
|
2019-12-27 13:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-02-20 05:51 |
|
Revised |
|
2020-02-22 07:05 |
|
Second Decision |
|
2020-03-19 06:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-03-22 21:21 |
|
Articles in Press |
|
2020-03-22 21:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-03-25 02:50 |
|
Publish the Manuscript Online |
|
2020-03-26 03:33 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Review |
| Article Title |
Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bo Yu, Xiao-Rong Li and Xiao-Min Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81800825 |
| National Natural Science Foundation of China |
81870651 |
| National Natural Science Foundation of China |
81870675 |
|
| Corresponding Author |
Xiao-Min Zhang, MD, PhD, Chief Doctor, Professor, Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, No. 251, Fukang Road, Tianjin 300384, China. xzhang08@tmu.edu.cn |
| Key Words |
Mesenchymal stem cells; Extracellular vesicles; Exosomes; Ocular diseases; Drug delivery; |
| Core Tip |
The therapeutic potential of Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) has been widely studied in various diseases. In the current review, we summarize all the studies about the use of MSC-derived EVs in different ocular disorders, such as corneal injury, glaucoma, uveitis and retinal diseases. We also discuss the history and properties of MSC-derived EVs, the advantages of their use in treating eye diseases and their drug delivery potential. This review also provides future directions for enhancing the therapeutic effect of MSC-derived EVs in treating ocular diseases. |
| Publish Date |
2020-03-26 03:33 |
| Citation |
Yu B, Li XR, Zhang XM. Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases. World J Stem Cells 2020; 12(3): 178-187 |
| URL |
https://www.wjgnet.com/1948-0210/full/v12/i3/178.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v12.i3.178 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
